Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard

Fort Wayne, Indiana 46804

0 studies enrolling now · 7 studies all time

What they study most

Adenocarcinoma of the Prostate, Breast Cancer, Clear Cell Renal Cell Carcinoma, Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fallopian Tube Carcinoma, Hormone-Resistant Prostate Cancer, Hormone-resistant Prostate Cancer, Ovarian Endometrioid Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma, Ovarian Serous Adenocarcinoma

Studies at this site

• Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer — Running, not enrolling
• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer — Running, not enrolling
• Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer — Status unconfirmed
• Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer — Completed
• Tivantinib in Treating Patients With Metastatic Prostate Cancer — Completed
• Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer — Completed